Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Cash from Financing Activities (2016 - 2025)

SRx Health Solutions' Cash from Financing Activities history spans 16 years, with the latest figure at $3.2 million for Q2 2025.

  • For Q2 2025, Cash from Financing Activities fell 17.89% year-over-year to $3.2 million; the TTM value through Jun 2025 reached $3.5 million, down 6.88%, while the annual FY2023 figure was -$5.1 million, 497.58% down from the prior year.
  • Cash from Financing Activities reached $3.2 million in Q2 2025 per SRXH's latest filing, up from -$1.2 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $34.4 million in Q3 2021 to a low of -$4.6 million in Q2 2023.
  • Average Cash from Financing Activities over 5 years is $2.3 million, with a median of -$95500.0 recorded in 2023.
  • Peak YoY movement for Cash from Financing Activities: tumbled 1934.67% in 2023, then surged 3509.33% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$552000.0 in 2021, then fell by 1.63% to -$561000.0 in 2022, then surged by 41.53% to -$328000.0 in 2023, then tumbled by 982.32% to -$3.6 million in 2024, then surged by 188.85% to $3.2 million in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Cash from Financing Activities are $3.2 million (Q2 2025), -$1.2 million (Q1 2025), and -$3.6 million (Q4 2024).